The purpose of this study is to assess the effect of bacterial lysates on respiratory tract microecology in patients with mechanical ventilation and the efficacy of prevention and treatment of ventilator associated pneumonia.
After being informed about the study and potential risks, all patients giving written informed consent will undergo a one-week screening period to determine eligibility for study entry. At week 0, patients who meet the eligibility requirements will be randomized in a double-blind manner in a 1:1 ratio to Bacterial Lysates( 14mg, once a day) or placebo(once a day).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
100
14mg once a day
14.0ml once a day
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China
RECRUITINGVAP incidence
The incidence rate of ventilator associated pneumonia
Time frame: 2 weeks
Assessment of human immune status
Immune status Assessment of IgG, IgA, and IgM levels Quantifications of IgG, IgA, and IgM levels were determined by Immunological Turbidity Kits
Time frame: one week
drug resistant bacteria Incidence
The incidence rate of drug resistant bacteria
Time frame: one week
Composition of respiratory bacteria
probiotics and pathogens via NGS analysis
Time frame: one week
survival rate
ICU in-hospital mortality and 28 day mortality
Time frame: 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.